Evaluating the clinical meaning of the Hidradenitis Suppurativa Clinical Response (HiSCR) - 21/04/16
Doi : 10.1016/j.jaad.2016.02.017
Le texte complet de cet article est disponible en PDF.
Alexandra Kimball, Harvard Medical School and Massachusetts General Hospital, Boston, MA, United States; Murali Sundaram, AbbVie Inc, North Chicago, IL, United States; Rohini Sen, Adelphi Values, Boston, MA, United States; Naijun Chen, AbbVie Inc, North Chicago, IL, United States; Alan Shields, Adelphi Values, Boston, MA, United States; Yihua Gu, AbbVie Inc, North Chicago, IL, United States; Martin Okun, Fort HealthCare, Fort Atkinson, WI, United States
Le texte complet de cet article est disponible en PDF.| Design, study conduct, and financial support for the study were provided by AbbVie; AbbVie participated in the interpretation of data, review, and approval of the abstract; all authors contributed to the development of the publication. |
© 2016
Publié par Elsevier Masson SAS.
Vol 74 - N° 5S1
P. AB4 - mai 2016 Retour au numéro
Article précédent
- Efficacy, safety, and patient satisfaction with a combined acne regimen of epiduo gel, acne specific moisturizer with sunscreen and foam wash for the treatment of acne vulgaris in adolescent student athletes
- Evolution of acne assessments and impact on acne medications: An evolving, imperfect paradigm
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?